Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis (Q33828160)

29 July 2017

Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis (English)

1 reference

metastatic renal cell carcinoma

29 July 2017

1 reference

1 reference

Tigrani VS

1

1 reference

29 July 2017

Reese DM

2

1 reference

29 July 2017

Small EJ

3

1 reference

29 July 2017

Presti JC Jr

4

1 reference

29 July 2017

Carroll PR

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

55

1 reference

29 July 2017

1

1 reference

29 July 2017

36-40

1 reference

29 July 2017

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

The natural history of metastatic renal cell carcinoma: a computer analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Spontaneous regression of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Is Nephrectomy Justified in Patients with Metastatic Renal Carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Prognostic factors in metastatic renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Efficacy of multimodality therapy in advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Pre-operatively determined prognostic factors in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900395-7

7 January 2021

10.1016/S0090-4295(99)00395-7

Identifiers

DOI

1 reference

29 July 2017

1 reference